Colorado State University has received $2 million in funding from the U.S. Department of Defense to work on the first Ebola vaccine.
“The reason why CSU was chosen as the best place to carry this out is because of the infectious disease infrastructure we have plus the investment BioMARC has made in infectious disease research,” Pierro said. “We have been inspected by the FDA and passed, so that sets us apart from other universities or facilities.”
Article Source: http://www.denverpost.com/news/ci_26809324/csu-wins-2-million-pentagon-contract-develop-ebola
This website uses cookies.